Phase
Condition
Multiple Sclerosis
Dizzy/fainting Spells
Low Blood Pressure (Hypotension)
Treatment
StableEyes
Clinical Study ID
Ages 18-89 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Neurologist-confirmed diagnosis of primary progressive or relapsing and remitting MSper the 2017 Revision of the McDonald Criteria and the Magnetic Resonance Imaging inMS
Fluent in speaking and understanding English
Have self-reported vestibular symptoms of dizziness, imbalance, and/or a history ofat least two falls in the prior 12 months
Exclusion
Exclusion Criteria:
Clinically isolated syndrome or radiologically isolated syndrome.
Worsening MS symptoms during the prior 60 days
Immunotherapy change in the prior 60 days
Self-reported cognitive impairment that limits independence with basic andinstrumental activities of daily living
Systolic blood pressure > 180 mmHg and/or diastolic blood pressure > 90 mmHg at rest
Static visual acuity with correction of worse than 1.0 logMAR
Manifest ocular misalignment ≥ 5 diopters (e.g., tropia, lazy eye, strabismus}
Convergence insufficiency
Intra-nuclear ophthalmoplegia
Benign paroxysmal positional vertigo
Major orthopedic conditions that limit cervical spine range of motion or that alterwalking
Self-reported current or potential for pregnancy during enrollment
Ongoing participation in vestibular rehabilitation for dizziness
Study Design
Study Description
Connect with a study center
Emory Univeristy
Atlanta, Georgia 30329
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.